Famotidine
NDC 57896-317, Famotidine, tablet, film coated, from GERI-CARE PHARMACEUTICAL CORP.
- Product NDC
- 57896-317
- Status
- Listed
- Labeler
- GERI-CARE PHARMACEUTICAL CORP
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA215822
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57896-317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FAMOTIDINE10 mg/1
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57896-317-03 | 57896031703 | 1 BOTTLE in 1 CARTON (57896-317-03) / 30 TABLET, FILM COATED in 1 BOTTLE |
| 57896-317-06 | 57896031706 | 1 BOTTLE in 1 CARTON (57896-317-06) / 60 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 57896-317 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57896-317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57896-317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.